Yüklüyor......
Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2
The effective therapeutic treatment and the disease-modifying therapy for spinocerebellar ataxia type 2 (SCA2) (a progressive hereditary disease caused by an expansion of polyglutamine in the ataxin-2 protein) is not available yet. At present, only symptomatic treatment and methods of palliative car...
Kaydedildi:
| Yayımlandı: | Neurotherapeutics |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985344/ https://ncbi.nlm.nih.gov/pubmed/31435879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00777-6 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|